{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:20:33Z","timestamp":1791159633025,"version":"4.1.0"},"reference-count":38,"publisher":"American Association for Cancer Research (AACR)","issue":"22","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Melanoma incidence is increasing worldwide, and metastatic melanoma is almost completely resistant to every known therapy. New approaches to treating melanoma are urgently needed, and a greater understanding of the biology of melanoma invasion and metastasis will aid in their creation. A high proportion of invasive melanomas have a constitutively active Raf\/mitogen-activated protein kinase\/extracellular signal-regulated kinase (MEK\/ERK) signaling cascade; however, the downstream effectors of ERK signaling that contribute to melanoma invasion and metastasis are unknown. ERK signaling drives the production of the interstitial collagenase matrix metalloproteinase-1 (MMP-1), which is expressed specifically by invasive melanomas. Using short hairpin RNAs (shRNA) to knock down MMP-1 expression in a human melanoma cell line, we investigated the role of MMP-1 in melanoma metastasis in a xenograft model. Knockdown of MMP-1 had no effect on primary tumor growth, but reduction of MMP-1 expression significantly decreased the ability of the melanoma to metastasize from the orthotopic site in the dermis to the lung. Mechanistically, tumor cells expressing MMP-1 shRNAs had diminished collagenase activity, which is required for tumor cell invasion. Additionally, attenuation of MMP-1 expression reduced angiogenesis. These results show, for the first time, that targeted inhibition of MMP-1, a single effector of the Raf\/MEK\/ERK signaling cascade, prevents the progression of melanoma from a primary to metastatic tumor and, as such, may represent a useful therapeutic tool in controlling this disease. [Cancer Res 2007;67(22):10849\u201358]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-1791","type":"journal-article","created":{"date-parts":[[2007,11,15]],"date-time":"2007-11-15T15:23:37Z","timestamp":1195140217000},"page":"10849-10858","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["RNA Interference Inhibition of Matrix Metalloproteinase-1 Prevents Melanoma Metastasis by Reducing Tumor Collagenase Activity and Angiogenesis"],"prefix":"10.1158","volume":"67","author":[{"given":"Jessica S.","family":"Blackburn","sequence":"first","affiliation":[{"name":"1Biochemistry and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Harker","family":"Rhodes","sequence":"additional","affiliation":[{"name":"3Department of Pathology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles I.","family":"Coon","sequence":"additional","affiliation":[{"name":"1Biochemistry and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance E.","family":"Brinckerhoff","sequence":"additional","affiliation":[{"name":"1Biochemistry and Departments of"},{"name":"2Medicine, Norris Cotton Cancer Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,11,15]]},"reference":[{"key":"2022061623191939100_B1","doi-asserted-by":"crossref","unstructured":"Balch C, Soong S-J, Atkins M, Buzaid A, Thompson J. An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin\u20082004; 54: 131\u201349.","DOI":"10.3322\/canjclin.54.3.131"},{"key":"2022061623191939100_B2","doi-asserted-by":"crossref","unstructured":"Leiter U, Friedegund M, Shittek B, Garbe C. The natural course of cutaneous melanoma. J Surg Oncol\u20082004; 86: 172\u20138.","DOI":"10.1002\/jso.20079"},{"key":"2022061623191939100_B3","doi-asserted-by":"crossref","unstructured":"Gogas H, Kirkwood J, Sondak V. Chemotherapy for metastatic melanoma. Cancer\u20082007; 109: 455\u201364.","DOI":"10.1002\/cncr.22427"},{"key":"2022061623191939100_B4","doi-asserted-by":"crossref","unstructured":"Uribe P, Andrade L, Gonzalez S. Lack of association between BRAF mutation and MAPK ERK activation in melanocytic nevi. J Invest Dermatol\u20082006; 126: 161\u20136.","DOI":"10.1038\/sj.jid.5700011"},{"key":"2022061623191939100_B5","doi-asserted-by":"crossref","unstructured":"Lopez-Bergami P, Huang C, Goydos J, et al. Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell\u20082007; 11: 447\u201360.","DOI":"10.1016\/j.ccr.2007.03.009"},{"key":"2022061623191939100_B6","unstructured":"Jorgensen K, Holm R, Maelandsmo G, Florenes V. Expression of activated extracellular signal-regulated kinases 1\/2 in malignant melanomas: relationship with clinical outcome. Clin Cancer Res\u20082003; 9: 5325\u201331."},{"key":"2022061623191939100_B7","unstructured":"Satyamoorthy K, Li G, Gerrero M, et al. Constitutive MAPK activation in melanoma is mediated by both BRAF mutation and autocrine growth factor stimulation. Cancer Res\u20082003; 63: 756\u20139."},{"key":"2022061623191939100_B8","doi-asserted-by":"crossref","unstructured":"Sharma A, Tran M, Liang S, et al. Targeting MAPK\/ERK in the mutant (V600E) B-Raf signaling cascade effectively inhibits melanoma lung metastasis. Cancer Res\u20082006; 66: 8200\u20139.","DOI":"10.1158\/0008-5472.CAN-06-0809"},{"key":"2022061623191939100_B9","doi-asserted-by":"crossref","unstructured":"Kolch W, Kotwaliwale A, Vass K, Janosch P. The role of Raf kinases in malignant transformation. Exp Rev Mol Med\u20082002; 25: 1\u201318.","DOI":"10.1017\/S1462399402004386"},{"key":"2022061623191939100_B10","doi-asserted-by":"crossref","unstructured":"Huntington JT, Shields JM, Der CJ, et al. Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells. J Bio Chem\u20082004; 279: 33168\u201376.","DOI":"10.1074\/jbc.M405102200"},{"key":"2022061623191939100_B11","doi-asserted-by":"crossref","unstructured":"Park CH, Lee MJ, Ahn J, et al. Heat shock-induced matrix metalloproteinase (MMP)-1 and MMP-3 are mediated through ERK and JNK activation and via an autocrine interleukin-6 loop. J Invest Dermatol\u20082004; 123: 1012\u20139.","DOI":"10.1111\/j.0022-202X.2004.23487.x"},{"key":"2022061623191939100_B12","doi-asserted-by":"crossref","unstructured":"Page-McCaw A, Ewald A, Werb Z. Matrix metalloproteinases and the regulation of tissue remodeling. Nat Rev Mol Cell Biol\u20082007; 8: 221\u201333.","DOI":"10.1038\/nrm2125"},{"key":"2022061623191939100_B13","doi-asserted-by":"crossref","unstructured":"Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol\u20082003; 200: 448\u201364.","DOI":"10.1002\/path.1400"},{"key":"2022061623191939100_B14","doi-asserted-by":"crossref","unstructured":"Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer\u20082000; 36: 1621\u201330.","DOI":"10.1016\/S0959-8049(00)00156-8"},{"key":"2022061623191939100_B15","doi-asserted-by":"crossref","unstructured":"Yoon S-O, Park S-J, Yun C-H, Chung A-S. Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. J Biochem Mol Biol\u20082003; 36: 128\u201337.","DOI":"10.5483\/BMBRep.2003.36.1.128"},{"key":"2022061623191939100_B16","doi-asserted-by":"crossref","unstructured":"Fingleton B. Matrix metalloproteinases: roles in cancer and metastasis. Front Biosci\u20082006; 11: 479\u201391.","DOI":"10.2741\/1811"},{"key":"2022061623191939100_B17","doi-asserted-by":"crossref","unstructured":"Walker R, Wooley DE. Immunolocalisation studies of matrix metalloproteinases-1, -2 and -3 in human melanoma. Virchows Arch\u20081999; 435: 574\u20139.","DOI":"10.1007\/s004280050443"},{"key":"2022061623191939100_B18","doi-asserted-by":"crossref","unstructured":"Airola K, Karonen T, Vaalamo M, et al. Expression of collagenase-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br J Cancer\u20081999; 80: 733\u201343.","DOI":"10.1038\/sj.bjc.6690417"},{"key":"2022061623191939100_B19","doi-asserted-by":"crossref","unstructured":"Kurschat P, Wickenhauser C, Groth W, Krieg T, Mauch C. Identification of activated MMP-2 as the main gelatinolytic enzyme in malignant melanoma by in situ zymography. J Pathol\u20082002; 197: 179\u201387.","DOI":"10.1002\/path.1080"},{"key":"2022061623191939100_B20","doi-asserted-by":"crossref","unstructured":"Hofmann U, Westphal J, Was E, et al. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated MMP-2 correlates with melanoma progression. Br J Cancer\u20081999; 81: 774\u201382.","DOI":"10.1038\/sj.bjc.6690763"},{"key":"2022061623191939100_B21","doi-asserted-by":"crossref","unstructured":"Benbow U, Schoenermark M, Mitchell T, et al. A novel host\/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen. J Bio Chem\u20081999; 274: 25371\u20138.","DOI":"10.1074\/jbc.274.36.25371"},{"key":"2022061623191939100_B22","doi-asserted-by":"crossref","unstructured":"Durko M, Navab R, Shibata H, Brodt P. Suppression of basement membrane type IV collagen degradation and cell invasion in human melanoma cells expressing an antisense RNA for MMP-1. Biochim Biophys Acta\u20081998; 1356: 271\u201380.","DOI":"10.1016\/S0167-4889(97)00004-9"},{"key":"2022061623191939100_B23","doi-asserted-by":"crossref","unstructured":"Iida J, McCarthy J. Expression of collagenase-1 (MMP-1) promotes melanoma growth through the generation of active transforming growth factor-\u03b2. Melanoma Res\u20082007; 17: 205\u201313.","DOI":"10.1097\/CMR.0b013e3282a660ad"},{"key":"2022061623191939100_B24","doi-asserted-by":"crossref","unstructured":"Wyatt CA, Geoghegan JC, Brinckerhoff CE. Short hairpin RNA-mediated inhibition of matrix metalloproteinase-1 in MDA-231 cells: effects on matrix destruction and tumor growth. Cancer Res\u20082005; 65: 11101\u20138.","DOI":"10.1158\/0008-5472.CAN-05-2446"},{"key":"2022061623191939100_B25","doi-asserted-by":"crossref","unstructured":"Meier F, Nesbit M, Hsu M, Martin B, Donatien P, Herlyn M. Human melanoma progression in skin reconstructs: biological significance of bFGF. Am J Pathol\u20082000; 156: 193\u2013200.","DOI":"10.1016\/S0002-9440(10)64719-0"},{"key":"2022061623191939100_B26","doi-asserted-by":"crossref","unstructured":"Nicklas J, Buel E. Development of an Alu-based, real-time PCR method for quantitation of human DNA in forensic samples. J Forensic Sci\u20082003; 48: 1\u20139.","DOI":"10.1520\/JFS2002414"},{"key":"2022061623191939100_B27","doi-asserted-by":"crossref","unstructured":"Ntayi C, Lorimier S, Berthier-Vergnes O, Hornebeck W, Bernard P. Cumulative influence of matrix metalloproteinase-1 and -2 in the migration of melanoma cells within three-dimensional type I collagen lattices. Exp Cell Res\u20082001; 270: 110\u20138.","DOI":"10.1006\/excr.2001.5306"},{"key":"2022061623191939100_B28","doi-asserted-by":"crossref","unstructured":"Hass T, Madri J. Extracellular matrix driven matrix metalloproteinase production in endothelial cells. Trends Cardiovasc Med\u20081999; 9: 70\u20137.","DOI":"10.1016\/S1050-1738(99)00014-6"},{"key":"2022061623191939100_B29","doi-asserted-by":"crossref","unstructured":"Handsley M, Edwards D. Metalloproteinases and their inhibitors in tumor angiogenesis. Int J Cancer\u20082005; 115: 849\u201360.","DOI":"10.1002\/ijc.20945"},{"key":"2022061623191939100_B30","doi-asserted-by":"crossref","unstructured":"Demikesesn C, Buyukpinarbasili N, Ramazanoglu R, Oguz O, Mandel N, Kaner G. The correlation of angiogenesis with metastasis in primary cutaneous melanoma: a comparative analysis of microvessel density, expression of VEGF and bFGF. Pathology\u20082006; 38: 132\u20137.","DOI":"10.1080\/00313020600557565"},{"key":"2022061623191939100_B31","doi-asserted-by":"crossref","unstructured":"Staton C, Stibbling S, Tazzyman S, Hughes R, Brown N, Lewis C. Current methods for assaying angiogenesis in vitro and in vivo. Int J Exp Pathol\u20082004; 85: 223\u201348.","DOI":"10.1111\/j.0959-9673.2004.00396.x"},{"key":"2022061623191939100_B32","doi-asserted-by":"crossref","unstructured":"Boire A, Covic L, Agarvai A, Jacques S, Sherifi S, Kuliopulos A. PAR1 is a matrix metalloproteinase-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell\u20082005; 120: 303\u201313.","DOI":"10.1016\/j.cell.2004.12.018"},{"key":"2022061623191939100_B33","doi-asserted-by":"crossref","unstructured":"Goerge T, Barg A, Schnaeker E-M, et al. Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation. Cancer Res\u20082006; 66: 7766\u201374.","DOI":"10.1158\/0008-5472.CAN-05-3897"},{"key":"2022061623191939100_B34","doi-asserted-by":"crossref","unstructured":"Tuveson DA, Weber BL, Herlyn M. BRAF as a potential therapeutic target in human cancer. Cancer Cell\u20082003; 4: 95\u20138.","DOI":"10.1016\/S1535-6108(03)00189-2"},{"key":"2022061623191939100_B35","doi-asserted-by":"crossref","unstructured":"Nikkola J, Vihinen P, Vuoristo M-S, Kellokumpu-Lehtinen P, Kahari V-M, Pyrhonen S. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma. Clin Cancer Res\u20082005; 11: 5158\u201366.","DOI":"10.1158\/1078-0432.CCR-04-2478"},{"key":"2022061623191939100_B36","doi-asserted-by":"crossref","unstructured":"Hofmann U, Westphal J, van Muijen G, Ruiter D. Matrix metalloproteinases in human melanoma. J Invest Dermatol\u20082000; 115: 337\u201344.","DOI":"10.1046\/j.1523-1747.2000.00068.x"},{"key":"2022061623191939100_B37","doi-asserted-by":"crossref","unstructured":"Smalley K, Lioni M, Heryln M. Targeting the stromal fibroblasts: a novel approach to melanoma therapy. Expert Rev Anticancer Ther\u20082005; 5: 1069\u201378.","DOI":"10.1586\/14737140.5.6.1069"},{"key":"2022061623191939100_B38","unstructured":"Pluda J. Tumor-associated angiogenesis: mechanisms, clinical implications and therapeutic strategies. Semin Oncol\u20081997; 24: 203\u201318."}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/22\/10849\/2576510\/10849.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/22\/10849\/2576510\/10849.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T22:17:58Z","timestamp":1655417878000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/22\/10849\/533825\/RNA-Interference-Inhibition-of-Matrix"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,15]]},"references-count":38,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2007,11,15]]},"published-print":{"date-parts":[[2007,11,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-1791","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22370126","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370129.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370129","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370126.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6496277","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6496277.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,15]]}}}